维巴科赛德可以扭转前额叶皮质的GABAergic缺陷,以缓解慢性压力诱导的抑郁症
Jin Pan1, Liuxuan Huang2, Peng Sun3
1The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Psychopharmacology
|September 12, 2025
概括
维巴科赛德 (VB) 通过降低miR-144-3p的调节来逆转压力诱导的抑郁症,恢复前额叶皮层的GABAergic神经元功能. 这种机制对于VB的抗抑郁作用至关重要.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 抑郁症与前额前部GABA缺乏和突触传输问题有关.
- 来自Baihe Dihuang蒸的Verbascoside (VB) 在解决这些缺陷方面显示出潜力.
- 需要阐明VB通过miRNAs/Gad-67/VGAT信号传递逆转压力诱导的GABAergic神经元功能障碍的精确机制.
研究的目的:
- 研究VB逆转压力诱导的异常前额前部GABAergic神经元功能障碍的机制.
- 确定miR-144-3p在VB抗抑郁作用和神经保护中的作用.
- 探索VB对GABAergic信号传递和肠道微生物群的影响.
主要方法:
- 利用慢性压力诱导的抑郁症和皮质激素 (CORT) 刺激的神经细胞损伤模型.
- 评估了VB的抗抑郁作用和神经保护功能.
- 监测前额前部GABAergic miR-144-3p表达,以评估VB对GABA释放的作用.
主要成果:
- 高的miR-144-3p表达与压力诱导的类似抑郁的行为和改变的GABA水平相关.
- VB治疗降低了miR-144-3p的调节,减轻了神经元损伤,改善了GABAergic缺陷.
- 过度表达miR-144-3p对抗VB的抗抑郁作用和神经保护,突出其关键作用.
结论:
- 对于VB的抗抑郁作用来说,中部前额叶皮层中GABAergic神经元的miR-144-3p下调是必不可少的.
- VB促进GABA释放和神经保护,通过抑制miR-144-3p进行中介.
- 维生素B影响肠道微生物群的组成,可能有助于其治疗效果.
相关概念视频
Anxiolytic Drugs: Overview
1.1K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.1K
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.4K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.4K
CNS Depressants: Barbiturates and Benzodiazepines
1.2K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.2K
Generalized Anxiety Disorder
645
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
645
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Stress Prevention and Stress Management Techniques IV
231
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
231


